FBN1 and obesity disorder: In the light of all this information, we show for the first time how the amount of asprosin changes in blood and saliva of underweight (thin), normal weight, and overweight individuals and participants with classes I, II, and III obesity and also whether or not salivary glands synthesize asprosin.